Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,828
Closed -$964K 205
2024
Q2
$964K Buy
+6,828
New +$848K 0.03% 129
2023
Q4
Sell
-181,477
Closed -$19.2M 189
2023
Q3
$19.2M Buy
181,477
+329
+0.2% +$38.1K 0.84% 44
2023
Q2
$21.6M Sell
181,148
-777
-0.4% -$80.3K 0.94% 45
2023
Q1
$16.9M Buy
181,925
+177,185
+3,738% +$15.5M 0.8% 46
2022
Q4
$387K Buy
+4,740
New +$360K 0.02% 187
2020
Q1
Sell
-34,022
Closed -$1.79M 423
2019
Q4
$1.79M Sell
34,022
-126,639
-79% -$6.97M 0.19% 127
2019
Q3
$8.65M Buy
160,661
+58,958
+58% +$3.26M 0.45% 54
2019
Q2
$5.78M Sell
101,703
-18,464
-15% -$999K 0.45% 55
2019
Q1
$6.39M Sell
120,167
-56,725
-32% -$2.89M 0.52% 45
2018
Q4
$7.98M Buy
176,892
+49,800
+39% +$2.39M 0.98% 22
2018
Q3
$6.54M Sell
127,092
-56,745
-31% -$2.76M 0.39% 77
2018
Q2
$8.13M Sell
183,837
-60,787
-25% -$2.8M 0.5% 53
2018
Q1
$11M Buy
244,624
+58,279
+31% +$2.9M 0.45% 59
2017
Q4
$8.91M Sell
186,345
-235,223
-56% -$11.5M 0.34% 80
2017
Q3
$20.3M Buy
421,568
+296,391
+237% +$14.7M 0.83% 29
2017
Q2
$6.27M Sell
125,177
-189,644
-60% -$8.64M 0.28% 120
2017
Q1
$14M Buy
+314,821
New +$13.1M 0.55% 49
2016
Q2
Sell
-122,390
Closed -$5.01M 224
2016
Q1
$5.01M Buy
+122,390
New +$4.53M 0.26% 122
2015
Q3
Sell
-299,164
Closed -$12.1M 258
2015
Q2
$12.1M Sell
299,164
-117,348
-28% -$5.09M 0.62% 55
2015
Q1
$18.1M Hold
416,512
0.87% 32
2014
Q4
$18.9M Buy
416,512
+7,048
+2% +$287K 0.86% 33
2014
Q3
$15.6M Buy
+409,464
New +$16.6M 0.72% 43
2014
Q1
Sell
-419,745
Closed -$16M 234
2013
Q4
$16M Sell
419,745
-168,796
-29% -$5.8M 0.94% 25
2013
Q3
$19.6M Buy
588,541
+310,213
+111% +$10.1M 1.38% 19
2013
Q2
$8.51M Buy
+278,328
New +$9.23M 0.64% 51

Other funds holding ORCL

Meag Munich Ergo's ORCL Position: Q3 2024 in Review

Meag Munich Ergo sold out of Oracle (ORCL) in Q3 2024, closing a stake of 6,828 shares — an estimated $964K sold.

Meag Munich Ergo first reported a position in ORCL in Q2 2013 and held it in 25 quarters. The position peaked at $21.6M in Q2 2023. 3,067 funds tracked by Wall St. Rank hold ORCL as of Q3 2024.

  • Meag Munich Ergo reported no remaining Oracle position as of Q3 2024 after selling out during the quarter.
  • Meag Munich Ergo sold 6,828 Oracle shares in Q3 2024, an estimated $964K.
  • Meag Munich Ergo first reported a position in Oracle in Q2 2013 and held it in 25 quarters.
  • Meag Munich Ergo's Oracle position peaked at $21.6M in Q2 2023.
  • 3,067 funds tracked by Wall St. Rank held Oracle as of Q3 2024.

Based on Meag Munich Ergo's 13F filing for Q3 2024, filed 11 Oct 2024.